Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants
Clinical trial NCT07182552 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07182552
- Sponsor
- Nanjing Chia-tai Tianqing Pharmaceutical
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2026-02-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.